The abstract is read at the publisher; the summary is JClub's.
Mosaic patient-derived human cortical organoids with DEPDC5 two-hit inactivation show increased mTOR activity, dysmorphic-like neurons, and heightened excitability that rapamycin rescues.
- Why it matters: FCDII is a leading cause of pediatric drug-resistant focal epilepsy, but how DEPDC5 mosaic biallelic loss disrupts human corticogenesis is not well modeled.
- What they did: The authors built proof-of-concept DEPDC5 two-hit mosaicism in patient-derived hCOs, then used rapamycin treatment, cellular phenotyping, and single-cell transcriptomics across three developmental stages.
- The result: Single-cell data revealed aberrant differentiation with premature upper-layer neuron generation, altered Notch and Wnt signaling, and changes in synaptic and epilepsy-associated genes, alongside cell-autonomous metabolism and translation defects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.